Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer | NEJM
Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized pro…